ChAdOx1‐S adenoviral vector vaccine applied intranasally elicits superior mucosal immunity compared to the intramuscular route of vaccination-Reference-Cited by-同舟云学术

ChAdOx1‐S adenoviral vector vaccine applied intranasally elicits superior mucosal immunity compared to the intramuscular route of vaccination

Published:2022-03-31 Issue:6 Volume:52 Page:936-945
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur J Immunol

Author:

Cokarić Brdovčak Maja¹,Materljan Jelena¹²,Šustić Marko¹,Ravlić Sanda³,Ružić Tina¹,Lisnić Berislav¹,Miklić Karmela¹,Brizić Ilija¹,Pribanić Matešić Marina¹,Juranić Lisnić Vanda¹,Halassy Beata³,Rončević Dobrica⁴,Knežević Zdravka⁵,Štefan Leo⁵,Bertoglio Federico⁶,Schubert Maren⁶,Čičin‐Šain Luka⁷,Markotić Alemka⁸,Jonjić Stipan¹^ORCID,Krmpotić Astrid²

Affiliation:

1. Center for Proteomics Faculty of Medicine University of Rijeka Rijeka Croatia

2. Department of Histology and Embryology University of Rijeka Rijeka Croatia

3. Centre for Research and Knowledge Transfer in Biotechnology University of Zagreb Zagreb Croatia

4. Teaching Institute of Public Health PGC Rijeka Croatia

5. JGL d.d. Jadran Galenski Laboratorij Rijeka Croatia

6. Institute for Biochemistry Biotechnology and Bioinformatics Technische Universität Braunschweig Braunschweig Germany

7. Department of Viral Immunology, Helmholtz Center for Infection Research Braunschweig Germany

8. Research Department University Hospital for Infectious Diseases “Fran Mihaljević” Zagreb Croatia

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/eji.202249823

Reference37 articles.

1. World Health Organization.WHO Coronavirus (COVID‐19) Dashboard. (2022). Available at:https://covid19.who.int/(Accessed: 12th January 2022).

2. Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology

3. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

4. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

5. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intranasal delivery of a recombinant adenovirus vaccine encoding the PEDV COE elicits potent mucosal and systemic antibody responses in mice;Microbiology Spectrum;2024-08-15

2. Immune surveillance of cytomegalovirus in tissues;Cellular & Molecular Immunology;2024-08-12

3. Mucoadhesive film for oral delivery of vaccines for protection of the respiratory tract;Journal of Controlled Release;2024-07

4. Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine;npj Vaccines;2024-06-26

5. Vaccine targeting to mucosal lymphoid tissues promotes humoral immunity in the gastrointestinal tract;Science Advances;2024-05-31